Browsing by Author "Sultan, Haider"
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- Evaluation of toxic impact of the synthetic cannabinoids JWH-018 and its N-(3-hydroxypentyl) metabolite on human cell linesPublication . Couceiro, Joana; Sultan, Haider; Duranovic, Smilja; Bell, Suzanne; Quintas, Alexandre
- Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell linesPublication . Couceiro, Joana; Bandarra, Susana; Sultan, Haider; Bell, Suzanne; Constantino, Susana; Quintas, Alexandre"The emergence and abuse of synthetic cannabinoids has been increasing as an alternative to cannabis, mainly among youth. As their appearance on the drug market has been recent, the pharmacological and toxicological profiles of these psychoactive substances are poorly understood. Current studies suggest that they have stronger effects compared to their natural alternatives and their metabolites retain affinity towards CB1 receptors in CNS. Since studies on its toxicological properties are scarce, the effects of the drug in human derived cell lines were investigated. The present study was designed to explore the toxicological impact of parent drug versus phase I metabolites of synthetic cannabinoids on human cells with and without CB1 receptor. The human cell line of neuroblastoma SH-SY5Y and human kidney cell line HEK-293T were exposed to JWH-018 and to its N-(3-hydroxypentyl) metabolite. Cell toxicity was evaluated using the MTT and LDH assay. Additionally, a dual staining methodology with fluorescent Annexin V-FITC and propidium iodide was performed to address the question of whether JWH-018 N-(3-hydroxypentyl) metabolite is inducing cell death through apoptosis or necrosis, in HEK293T and SH-SY5Y cell lines. The obtained results show that JWH-018 does not cause a statistically significant decrease in cell viability, in contrast to its N-(3-hydroxypentyl) metabolite, which at ≥25μM causes a significant decrease in cell viability. Both cell lines are affected by JWH-018 metabolite. Our results point to higher toxicity of JWH-018 metabolite when compared to its parent drug, suggesting a non-CB1 receptor mediated toxicological mechanism. Comparing the results from Annexin V/PI with MTT and LDH assays of SH-SY5Y and HEK293T in the presence of the synthetic cannabinoid metabolite, emerges the picture that cellular viability decreases and associated death is occurring through necrosis."
- Toxicological profile of JWH-018 and JWH-018 N-(3-Hydroxypentyl) metabolite in the HEK 293 T cell linePublication . Sultan, Haider; Quintas, Alexandre; Dias, Mário JoãoThe rise in use of synthetic cannabinoids as herbal smoking mixtures has been attributed to a number of reasons; primary among them being their “legality” and their promotion as being safer than the natural alternatives. As their emergence has been quite recent, their pharmacological and toxicological profiles are not known completely. One of the earliest synthetic cannabinoid to be detected in these herbal mixtures was JWH-018. In the present study, the cell toxicity of JWH-018 and its N-(3-hydroxypentyl) metabolite was investigated using human cell line HEK-293 T. The cell viability was assessed using the MTT assay after treatment with standard JWH-018 and its N-hydroxymetabolite in a concentration range between 1ng/ml to 5000ng/ml of both respectively. The results show that the highest concentration of 5000ng/ml shows statistically significant decrease in cell viability for both the parent compound and the metabolite when compared to cell controls. In addition, the metabolite also showed a statistically significant decrease in cell viability at a concentration of 2500ng/ml. There were also significant differences observed between the smaller concentrations (1ng/ml and 10ng/ml) when compared to the highest concentration (5000ng/ml) for both the parent compound and metabolite. The cytotoxic effect was seen at levels which are above the expected tissue levels after use of JWH-018 either by ingestion or smoking. The cytotoxicity of both the parent compound and the metabolite highlights the adverse effects these drugs may have with consequent need for further research and regulation.